Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:32 PM
Ignite Modification Date:
2025-12-24 @ 10:32 PM
NCT ID:
NCT02371135
Eligibility Criteria:
Inclusion Criteria:
* Male or Female age 18 or older
* Hereditary colorectal cancer syndrome with one of the following:
* Lynch syndrome, as defined by the presence of a deleterious germline mutation in the MLH1, MSH2, MSH6, PMS2 or EPCAM genes
* Other hereditary colonic polyposis syndromes, as defined by the presence of a deleterious germline mutation in any one of the following polyposis genes (APC, biallelic MYH, STK11, SMAD4, BMPR1A, or other CRC-risk associated genes at discretion of PI)
Exclusion Criteria:
* Unable to provide informed consent for testing
* Unable to complete English language questionnaire
* Receiving active chemotherapy
* Having completed active chemotherapy less then 12 months prior to day of scheduled lower endoscopy
* No infectious or drug induced colitis less then 12 months prior to day of scheduled lower endoscopy
* No history of inflammatory colitis (Crohn's disease or ulcerative colitis)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02371135
Study Brief:
Protocol Section:
NCT02371135